Table 2.

Clinical efficacy of TCZ treatment. All values represent median (

	Baseline	8 weeks	Wilcoxon signed-rank test, p value
DAS28	5.9 (4.7–6.8)	2.98 (2.0–3.8)	0.028
CDAI	32.4 (21.2–40.6)	6.7 (3.6–12.1)	0.005
SJC	9 (3–14)	1 (0–4.25)	0.009
TJC	10 (4–15)	1 (0–2.25)	0.017
ESR	34 (15–69)	6 (5–16)	0.001
CRP	11 (5–27)	1 (1–2)	0.005

All values represent median (IQR).

BL, baseline; CDAI, Clinical Disease Activity Index; CRP, C-reactive protein; DAS28, Disease Activity Score based on 28 joint count; ESR, erythrocyte sedimentation rate; SJC, swollen joint count; TJC, tender joint count.